Prof. Dr. Mustafa Karaagaç

Formation et spécialisation

1997–2003 Faculté de médecine de l’Université Ondokuz Mayıs — Études de médecine

2006–2010 Hôpital municipal Prof. Dr Cemil Taşcıoğlu — Spécialisation en médecine interne

2011–2014 Faculté de médecine Meram de l’Université Necmettin Erbakan — Spécialisation en oncologie médicale

Expérience

2017–2021 Faculté de médecine Meram de l’Université Necmettin Erbakan — Professeur assistant

2021–2022 Faculté de médecine Meram de l’Université Necmettin Erbakan — Professeur associé

Medical Park Samsun

Principaux domaines d’intérêt

Cancers du sein et du poumon

Cancers de la prostate et du côlon

Cancers gynécologiques

Immunothérapie et thérapies ciblées

Chimiothérapie personnalisée

Publications scientifiques sélectionnées

• Koçak MZ et al. Clinical Outcomes of Adjuvant Chemotherapy in Elderly Patients with Resected Stage II and III Colon Cancer: A Real-life Data. Osmangazi Journal of Medicine. 2025;47(4):623–629. DOI: 10.20515/otd.1657501.
• Korkmaz M et al. A new prognostic factor in patients with recurrent glioblastoma multiforme treated with bevacizumab plus irinotecan: Hemoglobin, albumin, lymphocytes and platelets (HALP) score. Archives of Current Medical Research. 2023. DOI: 10.47482/acmr.1175461.
• Karakurt Eryılmaz M, Korkmaz M, Karaağaç M, Artaç M. Otuz yaş altı meme kanserli kadınların klinikopatolojik özellikleri ve sağkalım sonuçları. Akdeniz Tıp Dergisi. 2023. DOI: 10.53394/akd.979443.
• Karaagac M, Yildiz O. The Clinical Features and Treatment Responses of Small Cell Lung Cancer Patients: A Single-Center Experience. Selcuk Medical Journal. 2020;36(1):27–32. DOI: 10.30733/std.2020.01450.
• Karaagac M, Artac M. Third-line Treatment is Associated with Prolonged Survival in Patients with Extensive-Stage Small Cell Lung Cancer: A Single Center Experience. EJMI. 2020;4(2):253–258. DOI: 10.14744/ejmi.2020.47601.
• Karaagac M et al. ERCC1 and XRCC1 single nucleotide polymorphisms can guide treatment decision in patients with metastatic non-small cell lung cancer. Medicine Science. 2020;9(1):255–260. DOI: 10.5455/medscience.2019.08.9184.
• Karaagac M, Karakurt Eryilmaz M. Pazopanib-induced fatal heart failure in a patient with unresectable soft tissue sarcoma and review of literature. Journal of Oncology Pharmacy Practice. 2020;26(3):768–774. DOI: 10.1177/1078155219875797.
• Araz M, Karaagac M, Korkmaz L, Beypinar I, Uysal M. The compliance with antiemetic guidelines of Turkish medical oncologists. A survey study of Turkish Oncology Group. Current Problems in Cancer. 2019;43(4):344–353. DOI: 10.1016/j.currproblcancer.2018.09.002.